These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2527811)

  • 1. Interaction between C3 and IL-2; inhibition of C3b binding to CR1 by IL-2.
    Bartók I; Erdei A; Mouzaki A; Osawa H; Szölösi J; Eigentler A; Diamantstein T; Dierich MP; Gergely J
    Immunol Lett; 1989 May; 21(2):131-7. PubMed ID: 2527811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of neutrophil expression of C3b receptors (CR1) by soluble monomeric human C3b.
    Porteu F; Mir A; Halbwachs-Mecarelli L
    Eur J Immunol; 1987 May; 17(5):629-35. PubMed ID: 2953614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assay of membrane complement receptors (CR1 and CR2) with C3b- and C3d-coated fluorescent microspheres.
    Lambris JD; Ross GD
    J Immunol; 1982 Jan; 128(1):186-9. PubMed ID: 7033372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of C3b receptors in the enhancement of interleukin-2-dependent T-cell proliferation.
    Erdei A; Spaeth E; Alsenz J; Rüde E; Schulz T; Gergely J; Dierich MP
    Mol Immunol; 1984 Dec; 21(12):1215-21. PubMed ID: 6240596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of the C3b receptor-binding domain in third component of complement.
    Becherer JD; Lambris JD
    J Biol Chem; 1988 Oct; 263(28):14586-91. PubMed ID: 2971659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unique role of the complement receptor CR1 in the degradation of C3b associated with immune complexes.
    Medof ME; Iida K; Mold C; Nussenzweig V
    J Exp Med; 1982 Dec; 156(6):1739-54. PubMed ID: 7175439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Common binding region of complement factors B, H and CR1 on C3b revealed by monoclonal anti-C3d.
    Koistinen V; Wessberg S; Leikola J
    Complement Inflamm; 1989; 6(4):270-80. PubMed ID: 2527715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression, molecular association, and functions of C3 complement receptors CR1 (CD35) and CR2 (CD21) on the human T cell line HPB-ALL.
    Delibrias CC; Fischer E; Bismuth G; Kazatchkine MD
    J Immunol; 1992 Aug; 149(3):768-74. PubMed ID: 1386093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factor I co-factor activity of CR1 overcomes the protective effect of IgG on covalently bound C3b residues.
    Fries LF; Prince GM; Gaither TA; Frank MM
    J Immunol; 1985 Oct; 135(4):2673-9. PubMed ID: 3161945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a C3bi-specific membrane complement receptor that is expressed on lymphocytes, monocytes, neutrophils, and erythrocytes.
    Ross GD; Lambris JD
    J Exp Med; 1982 Jan; 155(1):96-110. PubMed ID: 6915077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. gp140, a C3b-binding membrane component of lymphocytes, is the B cell C3dg/C3d receptor (CR2) and is distinct from the neutrophil C3dg receptor (CR4).
    Frade R; Myones BL; Barel M; Krikorian L; Charriaut C; Ross GD
    Eur J Immunol; 1985 Dec; 15(12):1192-7. PubMed ID: 3878789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutrophils express a receptor for iC3b, C3dg, and C3d that is distinct from CR1, CR2, and CR3.
    Vik DP; Fearon DT
    J Immunol; 1985 Apr; 134(4):2571-9. PubMed ID: 3156185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus regulates activation and processing of the third component of complement.
    Mold C; Bradt BM; Nemerow GR; Cooper NR
    J Exp Med; 1988 Sep; 168(3):949-69. PubMed ID: 2844953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural and functional studies on the human C3b/C4b receptor (CR1) purified by affinity chromatography using a monoclonal antibody.
    Holers VM; Seya T; Brown E; O'Shea JJ; Atkinson JP
    Complement; 1986; 3(2):63-78. PubMed ID: 2945695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Segment spanning residues 727-768 of the complement C3 sequence contains a neoantigenic site and accommodates the binding of CR1, factor H, and factor B.
    Becherer JD; Alsenz J; Esparza I; Hack CE; Lambris JD
    Biochemistry; 1992 Feb; 31(6):1787-94. PubMed ID: 1371073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human eosinophils express CR1 and CR3 complement receptors for cleavage fragments of C3.
    Fischer E; Capron M; Prin L; Kusnierz JP; Kazatchkine MD
    Cell Immunol; 1986 Feb; 97(2):297-306. PubMed ID: 3742611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of proteolytic activity of complement factor I by pH: C3b/C4b receptor (CR1) and membrane cofactor protein (MCP) have different pH optima for factor I-mediated cleavage of C3b.
    Seya T; Okada M; Nishino H; Atkinson JP
    J Biochem; 1990 Feb; 107(2):310-5. PubMed ID: 2141838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mapping of the C3b-binding site of CR1 and construction of a (CR1)2-F(ab')2 chimeric complement inhibitor.
    Kalli KR; Hsu PH; Bartow TJ; Ahearn JM; Matsumoto AK; Klickstein LB; Fearon DT
    J Exp Med; 1991 Dec; 174(6):1451-60. PubMed ID: 1836011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement receptors on Raji cells. The presence of a new type of C3 receptor.
    Okuda T; Tachibana T
    Immunology; 1980 Sep; 41(1):159-66. PubMed ID: 7429548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding of C3 and C3dg to the CR2 complement receptor induces growth of an Epstein-Barr virus-positive human B cell line.
    Hatzfeld A; Fischer E; Levesque JP; Perrin R; Hatzfeld J; Kazatchkine MD
    J Immunol; 1988 Jan; 140(1):170-5. PubMed ID: 2826586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.